Specialty Pharmaceutical Market to reach USD 108.5 billion by 2026

Speciality Pharmaceutical Market Size study, by Type (Oral pharmaceuticals, parenteral pharmaceuticals, Transdermal pharmaceuticals), by Application (Hospitals, Retail pharmacies, Speciality pharmacies, Mail order) and by Regional Forecasts 2019-2026
Product Code:  HALDAT_78028459
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Speciality Pharmaceutical Market, by Type, 2016-2026 (USD Billion)
1.3.2.	Speciality Pharmaceutical Market, by Application, 2016-2026 (USD Billion)
1.3.3.	Speciality Pharmaceutical Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Speciality Pharmaceutical Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Speciality Pharmaceutical Market Dynamics
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Speciality Pharmaceutical Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Speciality Pharmaceutical Market, by Type
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Speciality Pharmaceutical Market, Sub Segment Analysis
5.3.1.	Oral Pharmaceuticals
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	Parenteral Pharmaceuticals
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.	Transdermal Pharmaceuticals
5.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Speciality Pharmaceutical Market, by Application
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Speciality Pharmaceutical Market, Sub Segment Analysis
6.3.1.	Hospitals
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	Retail Pharmacies
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.	Speciality Pharmacies
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.	Mail Order
6.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7.	Speciality Pharmaceutical Market, by Regional Analysis
7.1.	Speciality Pharmaceutical Market, Regional Market Snapshot (2016-2026)
7.2.	North America Speciality Pharmaceutical Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.	Europe Speciality Pharmaceutical Market  Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.	Germany 
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.	France 
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.	Rest of Europe
7.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.4.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.	Asia Speciality Pharmaceutical Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.	Latin America Speciality Pharmaceutical Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.	Rest of The World 
7.6.1.	South America
7.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.	Middle East and Africa
7.6.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.2.	Types breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.2.3.	Applications breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	Purdue Pharma
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Product Summary
8.3.1.4.	Recent Developments
8.3.2.	Tevu Pharma
8.3.3.	SEP
8.3.4.	Shire
8.3.5.	Allergan
8.3.6.	Mallickrodt
8.3.7.	King Pharmaceutical
8.3.8.	Alcon
8.3.9.	Biogen idec
8.3.10.	Forest
8.3.11.	Gilead sciences
8.3.12.	Lundbeck
8.3.13.	Mundipharma
8.3.14.	Servier
8.3.15.	UCB
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Speciality Pharmaceutical Market is valued USD 74.4 billion in 2018 is anticipated to grow USD 108.5 billion with the compounded annual growth of 4.83% over the forecast period 2019-2026.
The market growth is primarily driven by increasing aging population, rising prevalence of chronic diseases and growing per capita healthcare expenditure. Furthermore, these are gaining traction in the pharma industry is due to lack of proper interventions for few disease conditions and faster regulatory approvals are driving the growth of this market. However, high cost of drugs and high research and development expenses hamper the market growth. Specialty pharmaceuticals are the drug molecules that help in treating specific genetic conditions which don’t have any therapeutic intervention in the market. Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs. Specialty pharmaceuticals include biopharmaceuticals, blood derived products and complex molecules.

The regional analysis of global Speciality Pharmaceutical market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to reimbursement for the specialty pharmaceuticals. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as high growth in biopharmaceutical industry would create lucrative growth prospects for the Speciality Pharmaceutical market across Asia-Pacific region.

Major market player included in this report are:
Amsoil Inc.
Bharat Petroleum Corporation Ltd.
BP Plc.
Chevron Corporation
China National Petroleum Corporation
China Petrochemical Corp.
Exxon Mobil Corporation
Fuchs Petrolub SE
Grazpromneft-lubricants, Ltd.
Gulf Oil Lubricants India Ltd.
Hindustan Petroleum Corp. Ltd.
Illinois Tool Works Inc.
Indian Oil Corporation Ltd.
JXTG Nippon Oil & Energy corporation
Kluber Lubrication

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

Oral pharmaceuticals
Parenteral pharmaceuticals
Transdermal pharmaceuticals

By Product:

Hospitals
Retail pharmacies
Speciality pharmacies
Mail order

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Speciality Pharmaceutical Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…